c ebpβ-lip drug Continuous Activation of C/EBPβ Transcription Factor Prevents Fibrosis Resolution After Alcohol Cessation Frontiers C/EBPβ sustains the oncogenic program
C EBP sustains the oncogenic program of AML cells by cooperating with MYB and co activator p300 in a transcriptional module Experimental Hematology C EBP LIP mediated activation of the malate aspartate shuttle sensitizes cells to glycolysis inhibition ScienceDirect C EBP beta Antibody Cell Signaling Technology Natural Products with Antitumor Potential Targeting the MYB C EBP p300 Transcription Module C EBP regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages Science Immunology c ebp lip drug Facts Continuous Activation of C EBP Transcription
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




